HomeClinical TopicsFDA approves new drug for certain types of ALL

FDA approves new drug for certain types of ALL

Author(s):

On March 29, the U.S. Food and Drug Administration (FDA) approved Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal residual disease.

Read more via FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content